Atara Biotherapeutics, Inc

(NASDAQ:ATRA)

Latest On Atara Biotherapeutics, Inc (ATRA):

Date/Time Type Description Signal Details
2023-05-12 06:30 ESTNewsAtara: MS Study Data Release And Other Catalysts Make This A Must WatchN/A
2023-05-08 21:14 ESTNewsAtara Biotherapeutics GAAP EPS of -$0.72 misses by $0.36, revenue of $1.23M misses by $29.45MN/A
2023-05-07 19:27 ESTNewsAtara Biotherapeutics Q1 2023 Earnings PreviewN/A
2023-03-11 10:50 ESTNewsSangamo, Protagonist, and Eiger among biotechs with exposure to Silicon Valley BankN/A
2023-02-18 02:59 ESTNewsAtara Biotherapeutics, Inc. 2023 Q4 - Results - Earnings Call PresentationN/A
2023-02-09 21:51 ESTNewsAtara Biotherapeutics: A Speculative Buy After A Difficult YearN/A
2023-02-08 18:48 ESTNewsAtara transfers rights for Ebvallo to Pierre Fabre in EU, certain other marketsN/A
2023-02-08 18:47 ESTNewsAtara Biotherapeutics GAAP EPS of -$0.72 misses by $0.30, revenue of $0.22M misses by $39.45MN/A
2023-02-08 05:15 ESTNewsAtara Biotherapeutics Q4 2022 Earnings PreviewN/A
2022-12-21 01:47 ESTNewsAtara Biotherapeutics, HealthCare Royalty ink $31M royalty interest financing dealN/A
2022-12-17 11:14 ESTNewsConsider Atara Biotherapeutics As The Tab-Cel Delay Resolves In The U.S.N/A
2022-11-09 02:35 ESTNewsAtara Biotherapeutics GAAP EPS of -$0.82 misses by $0.03, revenue of $4.46M beats by $0.72MN/A
2022-11-09 02:34 ESTNewsAtara Biotherapeutics, Inc. (ATRA) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 08:22 ESTNewsAtara Biotherapeutics Q3 2022 Earnings PreviewN/A
2022-10-14 14:08 ESTNewsEMA panel backs approval of Atara's Ebvallo for transplant complicationN/A
2022-09-29 06:51 ESTNewsAtara Bio to get additional $30M milestone payment under collaboration with Pierre FabreN/A
2022-08-18 07:24 ESTNewsAtara: 2 Possible Regulatory Approvals For Tab-Cel, Plus CAR T PipelineN/A
2022-08-09 18:59 ESTNewsAtara stock rises ~27% on Q2 beat, US regulatory path for tab-cel; to cut 20% staffN/A
2022-08-08 19:56 ESTNewsAtara Biotherapeutics GAAP EPS of $0.18 beats by $1.14, revenue of $51.58M beats by $45.05MN/A
2022-08-08 19:55 ESTNewsAtara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-06 06:21 ESTNewsAtara Biotherapeutics Q2 2022 Earnings PreviewN/A
2022-07-20 18:52 ESTNewsAtara slips as Citi downgrades to Sell on data for multiple sclerosis therapyN/A
2022-07-13 12:37 ESTNewsAtara plunges 56% as Stifel downgrades after early data for multiple sclerosis drugN/A
2022-07-12 23:07 ESTNewsAtara adds 16% ahead of Phase 2 data for multiple sclerosis candidateN/A
2022-07-12 23:07 ESTNewsAtara sinks on interim analysis of phase 2 study for multiple sclerosis candidateN/A
2022-05-24 14:21 ESTNewsAtara price target lowered at H.C. Wainwright as partnership with Bayer endsN/A
2022-05-19 17:21 ESTNewsBayer to end collaboration with Atara Biotherapeutics to develop CAR T-cell therapiesN/A
2022-05-10 02:23 ESTNewsAtara Biotherapeutics falls 16% following Citi downgrade to neutralN/A
2022-05-06 19:54 ESTNewsAtara Biotherapeutics, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-05 22:16 ESTNewsAtara Biotherapeutics GAAP EPS of -$0.87 beats by $0.14, revenue of $7.31M beats by $2.98MN/A
2022-05-05 22:16 ESTNewsAtara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 23:27 ESTNewsAtara Biotherapeutics Q1 2022 Earnings PreviewN/A
2022-04-09 19:28 ESTNewsAtara Biotherapeutics (ATRA) Investor Presentation - SlideshowN/A
2022-04-05 21:25 ESTNewsAtara Biotherapeutics names new technical chiefN/A
2022-03-01 03:13 ESTNewsAtara Biotherapeutics GAAP EPS of -$0.96 misses by $0.37, revenue of $7.55M misses by $27.59MN/A
2022-03-01 03:13 ESTNewsAtara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 03:13 ESTNewsAtara Biotherapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-28 07:15 ESTNewsAtara Biotherapeutics Q4 2021 Earnings PreviewN/A
2022-02-27 11:29 ESTNewsAtara Biotherapeutics: Early Stage Promises, Late Stage DelaysN/A
2022-02-18 09:23 ESTNewsAtara crashes after fatal adverse event in CAR T trialN/A
2022-01-14 20:31 ESTNewsAtara Biotherapeutics (ATRA) Investor Presentation (Slideshow)N/A
2022-01-07 01:29 ESTNewsAtara extends partnership with Be The Match BioTherapies for donor cellsN/A
2021-12-13 15:39 ESTNewsAtara: Inordinate FDA Delays Wrecked This StockN/A
2021-12-09 16:23 ESTNewsAtara shares early Phase 1 data for autologous CAR-T candidate in mesotheliomaN/A
2021-12-04 04:36 ESTNewsAtara Biotherapeutics announces inducement grants to new employeesN/A
2021-11-22 19:29 ESTNewsAtara Biotherapeutics, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-05 01:29 ESTNewsAtara Biotherapeutics EPS beats by $0.06, beats on revenueN/A
2021-11-05 01:28 ESTNewsAtara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 04:18 ESTNewsAtara Biotherapeutics Q3 2021 Earnings PreviewN/A
2021-10-13 17:26 ESTNewsAtara highlights long-term data from early-stage ATA188 multiple sclerosis trialN/A

About Atara Biotherapeutics, Inc (ATRA):

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA2321 for acute myeloid leukemia; and ATA368 for human papillomavirus. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

ATRA Quotes by TradingView

See Advanced Chart

General

  • Name Atara Biotherapeutics, Inc
  • Symbol ATRA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 437
  • Fiscal Year EndDecember
  • IPO Date2014-10-16
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.atarabio.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.96
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.80
  • Next Year EPS Estimate -$3.62
  • Next Quarter EPS Estimate -$0.96
  • Return on Assets -41%
  • Return on Equity -81%
  • Earnings Per Share -$6.07
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.26 billion
  • EBITDA -279340992
  • PE Ratio -0.21
  • Analyst Target Price $35.57
  • Book Value Per Share $5.55
View More

Share Statistics

  • Shares Outstanding 83.61 million
  • Shares Float 59.5 million
  • % Held by Insiders 93%
  • % Held by Institutions 102.01%
  • Shares Short 11.1 million
  • Shares Short Prior Month 11.74 million
  • Short Ratio 13.71
  • Short % of Float 15%
  • Short % of Shares Outstanding 13%
View More

Technicals

  • Beta 2.52
  • 52 Week High $26.1
  • 52 Week Low $7.14
  • 50 Day Moving Average 17.84
  • 200 Day Moving Average 17.67
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Atara Biotherapeutics, Inc (ATRA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Atara Biotherapeutics, Inc (ATRA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.95-$0.75-27.24%
2020-09-302020-11-09$N/A-$0.92-$1.0814.63%
2020-06-302020-08-05$N/A-$1.14-$1.183.63%
2020-03-312020-05-06$N/A-$1.20-$1.4115.16%
2019-12-312020-02-27$N/A-$1.36-$1.34-1.45%
2019-09-302019-11-07$N/A-$1.31-$1.449.19%
2019-06-302019-08-08$N/A-$1.60-$1.50-6.96%
2019-03-312019-05-09$N/A-$1.44-$1.514.92%
2018-12-312019-02-26$N/A-$1.75-$1.33-31.57%
2018-09-302018-11-06$N/A-$1.29-$1.13-14.39%
2018-06-302018-08-01$N/A-$1.15-$0.98-17.7%
2018-03-312018-05-08$N/A-$1.05-$0.92-13.69%
2017-12-312018-02-27$N/A-$1.15-$1.14-1.29%
2017-09-302017-11-09$N/A-$1.02-$0.98-4.09%
2017-06-302017-08-07$N/A-$0.94-$0.85-11.2%
2017-03-312017-05-04$N/A-$0.88-$0.75-18.01%
2016-12-312017-03-09$N/A-$0.63-$0.9835.75%
2016-09-302016-11-04$N/A-$0.88-$0.77-13.64%
2016-06-302016-08-08$N/A-$0.66-$0.61-7.65%
2016-03-312016-05-05$N/A-$0.58-$0.603.73%
2015-12-312016-03-03$N/A-$0.75-$0.48-57.2%
2015-09-302015-11-05$N/A-$0.43-$0.5623.21%
2015-06-302015-08-06$N/A-$0.43-$0.442.27%
2015-03-312015-05-07$N/A-$0.42-$0.444.55%
2014-12-312015-02-26$N/A-$0.67-$0.35-91.43%

Atara Biotherapeutics, Inc (ATRA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Atara Biotherapeutics, Inc (ATRA) Chart:

Atara Biotherapeutics, Inc (ATRA) News:

Below you will find a list of latest news for Atara Biotherapeutics, Inc (ATRA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Atara Biotherapeutics, Inc (ATRA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-12-200.50CALL0 00TRUE00
2024-12-2010CALL0 70TRUE00
2024-12-201.50CALL0 00TRUE00
2024-12-2020CALL0 00TRUE00
2024-12-202.50CALL0 00TRUE00
2024-12-2050CALL0 00TRUE00
2024-12-207.50CALL0 00TRUE00
2024-12-200.50PUT0 00FALSE00
2024-12-2010PUT0 00FALSE00
2024-12-201.50PUT0 00FALSE00
2024-12-2020PUT0 00FALSE00
2024-12-202.50PUT0 00FALSE00
2024-12-2050PUT0 00FALSE00
2024-12-207.50PUT0 00FALSE00

Latest ATRA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST70$5.065
Jun 13, 2022 7:59 PM EST23$5.065
Jun 13, 2022 7:59 PM EST100$5.065
Jun 13, 2022 7:59 PM EST9$5.07
Jun 13, 2022 7:59 PM EST20$5.06

Atara Biotherapeutics, Inc (ATRA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120039077/0001209191-20-039077-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000021545719003281/0000215457-19-003281-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000031506619000880/0000315066-19-000880-index.htm
2019-08-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000031506619001663/0000315066-19-001663-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000083423720004800/0000834237-20-004800-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000089542119000098/0000895421-19-000098-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000093247119005121/0000932471-19-005121-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000094787120000127/0000947871-20-000127-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000110465920018628/0001104659-20-018628-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000110465920021811/0001104659-20-021811-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000114420419007945/0001144204-19-007945-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000114420419008075/0001144204-19-008075-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000117266119000551/0001172661-19-000551-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000117266119000817/0001172661-19-000817-index.htm
2019-11-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000117266119002100/0001172661-19-002100-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000117266120000784/0001172661-20-000784-index.htm
2019-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000119312519030934/0001193125-19-030934-index.htm
2019-02-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604464/000119312519050875/0001193125-19-050875-index.htm
2019-02-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1604464/000119312519050879/0001193125-19-050879-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1604464/000119312519129473/0001193125-19-129473-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1604464/000119312519129496/0001193125-19-129496-index.htm
2019-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000119312519158431/0001193125-19-158431-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000119312519165471/0001193125-19-165471-index.htm
2019-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000119312519186073/0001193125-19-186073-index.htm
2019-07-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604464/000119312519196503/0001193125-19-196503-index.htm
2019-07-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604464/000119312519198171/0001193125-19-198171-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000119312519199083/0001193125-19-199083-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000119312519274911/0001193125-19-274911-index.htm
2020-02-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604464/000119312520051170/0001193125-20-051170-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1604464/000119312520052798/0001193125-20-052798-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000119312520128997/0001193125-20-128997-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000119312520140477/0001193125-20-140477-index.htm
2020-05-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604464/000119312520151515/0001193125-20-151515-index.htm
2020-05-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604464/000119312520153246/0001193125-20-153246-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000119312520154264/0001193125-20-154264-index.htm
2020-06-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1604464/000119312520162166/0001193125-20-162166-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000119312520174063/0001193125-20-174063-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119003315/0001209191-19-003315-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119005448/0001209191-19-005448-index.htm
2019-02-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119006607/0001209191-19-006607-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119008504/0001209191-19-008504-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119008508/0001209191-19-008508-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119008514/0001209191-19-008514-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119008518/0001209191-19-008518-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119008521/0001209191-19-008521-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119008526/0001209191-19-008526-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119008568/0001209191-19-008568-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119009116/0001209191-19-009116-index.htm
2019-02-124/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119009507/0001209191-19-009507-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119009508/0001209191-19-009508-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119011175/0001209191-19-011175-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119011179/0001209191-19-011179-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119011187/0001209191-19-011187-index.htm
2019-03-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119014938/0001209191-19-014938-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119014941/0001209191-19-014941-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119014944/0001209191-19-014944-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119017038/0001209191-19-017038-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119019979/0001209191-19-019979-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119020276/0001209191-19-020276-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119021441/0001209191-19-021441-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119021442/0001209191-19-021442-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119021443/0001209191-19-021443-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119021444/0001209191-19-021444-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119021445/0001209191-19-021445-index.htm
2019-04-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119021971/0001209191-19-021971-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119021972/0001209191-19-021972-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119023491/0001209191-19-023491-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119024245/0001209191-19-024245-index.htm
2019-04-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119024482/0001209191-19-024482-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119026446/0001209191-19-026446-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119027981/0001209191-19-027981-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119028232/0001209191-19-028232-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119030024/0001209191-19-030024-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119033638/0001209191-19-033638-index.htm
2019-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119038912/0001209191-19-038912-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119038914/0001209191-19-038914-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119039762/0001209191-19-039762-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119039763/0001209191-19-039763-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119039765/0001209191-19-039765-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119039767/0001209191-19-039767-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119039770/0001209191-19-039770-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119039802/0001209191-19-039802-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919119051095/0001209191-19-051095-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120005140/0001209191-20-005140-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120008125/0001209191-20-008125-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120008126/0001209191-20-008126-index.htm
2020-02-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120010846/0001209191-20-010846-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120010848/0001209191-20-010848-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120015349/0001209191-20-015349-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120015351/0001209191-20-015351-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120015360/0001209191-20-015360-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120015362/0001209191-20-015362-index.htm
2020-03-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120021698/0001209191-20-021698-index.htm
2020-03-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120021699/0001209191-20-021699-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120023763/0001209191-20-023763-index.htm
2020-04-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120025224/0001209191-20-025224-index.htm
2020-04-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120025229/0001209191-20-025229-index.htm
2020-04-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120026419/0001209191-20-026419-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120026420/0001209191-20-026420-index.htm
2020-05-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120028468/0001209191-20-028468-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120028472/0001209191-20-028472-index.htm
2020-05-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120030711/0001209191-20-030711-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120030712/0001209191-20-030712-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120031004/0001209191-20-031004-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120031005/0001209191-20-031005-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120031007/0001209191-20-031007-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120035488/0001209191-20-035488-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120037364/0001209191-20-037364-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120037365/0001209191-20-037365-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120037366/0001209191-20-037366-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120037367/0001209191-20-037367-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120037368/0001209191-20-037368-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120037478/0001209191-20-037478-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120039077/0001209191-20-039077-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120047819/0001209191-20-047819-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120047820/0001209191-20-047820-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604464/000120919120047821/0001209191-20-047821-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000156459019004254/0001564590-19-004254-index.htm
2019-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1604464/000156459019004275/0001564590-19-004275-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000156459019010713/0001564590-19-010713-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000156459019017589/0001564590-19-017589-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604464/000156459019017599/0001564590-19-017599-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000156459019030421/0001564590-19-030421-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604464/000156459019030426/0001564590-19-030426-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000156459019041365/0001564590-19-041365-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604464/000156459019041368/0001564590-19-041368-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000156459020007026/0001564590-20-007026-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1604464/000156459020007027/0001564590-20-007027-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1604464/000156459020017935/0001564590-20-017935-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1604464/000156459020017939/0001564590-20-017939-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000156459020021930/0001564590-20-021930-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604464/000156459020021960/0001564590-20-021960-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604464/000156459020036783/0001564590-20-036783-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604464/000156459020036808/0001564590-20-036808-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000156761920003339/0001567619-20-003339-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000165495419001523/0001654954-19-001523-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604464/000165495419008578/0001654954-19-008578-index.htm
2019-03-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1604464/999999999719000936/9999999997-19-000936-index.htm

Atara Biotherapeutics, Inc (ATRA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Atara Biotherapeutics, Inc (ATRA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 93%
Institutional Ownership: 10201%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-16Carol Giltner GallagherDirectorBuy8,000.00100,818.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120037367/0001209191-20-037367-index.htm
2020-06-16Roy D. BaynesDirectorBuy8,000.0012,000.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120037364/0001209191-20-037364-index.htm
2020-08-18Joe NewellChief Operations OfficerSell1,678.0012.0920,287.02122,203.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120047819/0001209191-20-047819-index.htm
2020-05-18Joe NewellChief Operations OfficerSell1,603.0011.2217,985.66123,881.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120031007/0001209191-20-031007-index.htm
2019-06-27WILLIAM K HEIDENDirectorBuy4,000.0012,500.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119039763/0001209191-19-039763-index.htm
2020-04-06Joe NewellChief Operations OfficerSell657.007.945,216.58125,484.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120023763/0001209191-20-023763-index.htm
2020-03-27Joe NewellChief Operations OfficerSell2,740.009.1725,125.80126,141.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120021698/0001209191-20-021698-index.htm
2020-03-01Joe NewellChief Operations OfficerBuy75,000.00128,881.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120015351/0001209191-20-015351-index.htm
2020-08-18Utpal KoppikarChief Financial OfficerSell1,496.0012.0918,086.64133,530.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120047820/0001209191-20-047820-index.htm
2020-06-09Utpal KoppikarChief Financial OfficerSell3,924.0010.1839,946.32135,026.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120035488/0001209191-20-035488-index.htm
2020-03-27Utpal KoppikarChief Financial OfficerSell1,827.009.1716,753.59137,330.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120021699/0001209191-20-021699-index.htm
2020-05-18Utpal KoppikarChief Financial OfficerSell1,428.0011.2216,022.16137,375.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120031005/0001209191-20-031005-index.htm
2020-03-01Utpal KoppikarChief Financial OfficerBuy66,875.00139,157.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120015362/0001209191-20-015362-index.htm
2019-06-24Pascal TouchonPresident and CEOBuy140,074.00140,074.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119038914/0001209191-19-038914-index.htm
2019-06-27ERIC DOBMEIERDirectorBuy2,000.0019.5039,000.0016,000.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119039770/0001209191-19-039770-index.htm
2019-06-27BETH C SEIDENBERGDirectorBuy4,000.0019,189.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119039802/0001209191-19-039802-index.htm
2019-06-27ERIC DOBMEIERDirectorBuy4,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119039770/0001209191-19-039770-index.htm
2020-06-16WILLIAM K HEIDENDirectorBuy8,000.0020,500.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120037368/0001209191-20-037368-index.htm
2019-02-15Derrell PorterSVP, Head of Global CommercialSell5,909.0040.00236,360.0021,688.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119011175/0001209191-19-011175-index.htm
2019-02-06Derrell PorterSVP, Head of Global CommercialBuy12,313.0023,597.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119008508/0001209191-19-008508-index.htm
2019-06-27Matthew K FustDirectorBuy4,000.0025,854.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119039765/0001209191-19-039765-index.htm
2020-08-18Pascal TouchonPresident and CEOSell4,807.0012.0958,116.63260,037.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120047821/0001209191-20-047821-index.htm
2020-06-25Pascal TouchonPresident and CEOSell12,135.0012.92156,784.20264,844.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120039077/0001209191-20-039077-index.htm
2020-06-16BETH C SEIDENBERGDirectorBuy8,000.0027,189.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120037478/0001209191-20-037478-index.htm
2019-02-15Christopher HaqqEVP, R&D & Chief Scientific OfSell775.0039.5930,682.25271,943.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119011187/0001209191-19-011187-index.htm
2019-02-11Christopher HaqqEVP, R&D & Chief Scientific OfSell13,975.0038.55538,736.25272,718.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119009116/0001209191-19-009116-index.htm
2019-02-06Christopher HaqqEVP, R&D & Chief Scientific OfSell9,698.0038.78376,088.44273,205.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119008526/0001209191-19-008526-index.htm
2019-02-15Derrell PorterSVP, Head of Global CommercialBuy4,000.0014.3057,200.0027,597.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119011175/0001209191-19-011175-index.htm
2020-05-18Pascal TouchonPresident and CEOSell3,195.0011.2235,847.90276,979.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120031004/0001209191-20-031004-index.htm
2020-06-16ERIC DOBMEIERDirectorBuy8,000.0028,000.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120037365/0001209191-20-037365-index.htm
2020-03-01Pascal TouchonPresident and CEOBuy150,000.00280,174.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120015349/0001209191-20-015349-index.htm
2019-02-06Christopher HaqqEVP, R&D & Chief Scientific OfSell2,677.0038.04101,833.08282,903.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119008526/0001209191-19-008526-index.htm
2019-02-06Christopher HaqqEVP, R&D & Chief Scientific OfBuy15,000.00286,693.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119008526/0001209191-19-008526-index.htm
2019-05-30Isaac E. CiechanoverChief Executive OfficerSell1,500.0023.7035,550.00290,687.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119033638/0001209191-19-033638-index.htm
2019-05-30Isaac E. CiechanoverChief Executive OfficerSell1,425.0022.7232,376.00292,187.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119033638/0001209191-19-033638-index.htm
2019-05-29Isaac E. CiechanoverChief Executive OfficerSell725.0023.3016,892.50293,612.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119033638/0001209191-19-033638-index.htm
2019-05-29Isaac E. CiechanoverChief Executive OfficerSell2,200.0022.8550,270.00294,337.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119033638/0001209191-19-033638-index.htm
2019-01-24Isaac E. CiechanoverChief Executive OfficerSell430.0035.8215,402.60296,452.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119005448/0001209191-19-005448-index.htm
2019-05-14Isaac E. CiechanoverChief Executive OfficerSell3,900.0024.9297,188.00296,537.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119030024/0001209191-19-030024-index.htm
2019-01-24Isaac E. CiechanoverChief Executive OfficerSell3,470.0034.98121,380.60296,882.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119005448/0001209191-19-005448-index.htm
2019-01-23Isaac E. CiechanoverChief Executive OfficerSell100.0036.583,658.00300,352.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119005448/0001209191-19-005448-index.htm
2019-05-13Isaac E. CiechanoverChief Executive OfficerSell400.0024.959,980.00300,437.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119030024/0001209191-19-030024-index.htm
2019-01-23Isaac E. CiechanoverChief Executive OfficerSell800.0035.5928,472.00300,452.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119005448/0001209191-19-005448-index.htm
2019-05-13Isaac E. CiechanoverChief Executive OfficerSell3,500.0024.2384,805.00300,837.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119030024/0001209191-19-030024-index.htm
2019-01-23Isaac E. CiechanoverChief Executive OfficerSell3,000.0034.84104,520.00301,252.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119005448/0001209191-19-005448-index.htm
2019-04-26Isaac E. CiechanoverChief Executive OfficerSell3,900.0033.47130,533.00304,337.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119026446/0001209191-19-026446-index.htm
2019-04-25Isaac E. CiechanoverChief Executive OfficerSell300.0033.9910,197.00308,237.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119026446/0001209191-19-026446-index.htm
2019-04-25Isaac E. CiechanoverChief Executive OfficerSell3,600.0033.57120,852.00308,537.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119026446/0001209191-19-026446-index.htm
2019-04-11Isaac E. CiechanoverChief Executive OfficerSell3,900.0036.27141,453.00312,137.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119024482/0001209191-19-024482-index.htm
2019-04-10Isaac E. CiechanoverChief Executive OfficerSell3,900.0037.04144,456.00316,037.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119024482/0001209191-19-024482-index.htm
2019-03-26Derrell PorterSVP, Head of Global CommercialBuy10,000.0031,688.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021441/0001209191-19-021441-index.htm
2019-02-02Joe NewellChief Tech. Operations OfficerSell500.0038.4419,220.0031,858.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119006607/0001209191-19-006607-index.htm
2019-03-29Isaac E. CiechanoverChief Executive OfficerSell200.0041.708,340.00319,937.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021972/0001209191-19-021972-index.htm
2019-03-29Isaac E. CiechanoverChief Executive OfficerSell3,700.0039.81147,297.00320,137.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021972/0001209191-19-021972-index.htm
2019-02-01Joe NewellChief Tech. Operations OfficerSell1,000.0037.8037,800.0032,358.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119006607/0001209191-19-006607-index.htm
2019-03-28Isaac E. CiechanoverChief Executive OfficerSell300.0038.5911,577.00323,837.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021972/0001209191-19-021972-index.htm
2019-03-28Isaac E. CiechanoverChief Executive OfficerSell1,600.0038.0260,832.00324,137.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021972/0001209191-19-021972-index.htm
2019-03-28Isaac E. CiechanoverChief Executive OfficerSell2,000.0036.7573,500.00325,737.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021972/0001209191-19-021972-index.htm
2019-02-27JOEL S MARCUSDirectorBuy25,000.0025.15628,750.0032,590.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119014941/0001209191-19-014941-index.htm
2019-03-15Isaac E. CiechanoverChief Executive OfficerSell3,900.0038.73151,047.00327,737.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119019979/0001209191-19-019979-index.htm
2019-03-14Isaac E. CiechanoverChief Executive OfficerSell3,200.0040.48129,536.00331,637.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119019979/0001209191-19-019979-index.htm
2019-02-01Joe NewellChief Tech. Operations OfficerBuy1,500.0020.4030,600.0033,358.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119006607/0001209191-19-006607-index.htm
2019-03-14Isaac E. CiechanoverChief Executive OfficerSell700.0039.1027,370.00334,837.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119019979/0001209191-19-019979-index.htm
2019-02-28Isaac E. CiechanoverChief Executive OfficerSell3,900.0036.13140,907.00335,537.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119014944/0001209191-19-014944-index.htm
2020-06-16Matthew K FustDirectorBuy8,000.0033,854.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120037366/0001209191-20-037366-index.htm
2019-02-27Isaac E. CiechanoverChief Executive OfficerSell3,700.0036.20133,940.00339,437.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119014944/0001209191-19-014944-index.htm
2019-02-12Isaac E. CiechanoverChief Executive OfficerSell3,900.0039.01152,139.00342,138.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119009508/0001209191-19-009508-index.htm
2019-02-27Isaac E. CiechanoverChief Executive OfficerSell200.0035.227,044.00343,137.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119014944/0001209191-19-014944-index.htm
2019-02-11Isaac E. CiechanoverChief Executive OfficerSell3,900.0038.52150,228.00346,038.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119009508/0001209191-19-009508-index.htm
2019-06-27Roy D. BaynesDirectorBuy4,000.004,000.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119039762/0001209191-19-039762-index.htm
2019-01-10Isaac E. CiechanoverChief Executive OfficerSell2,200.0034.5075,900.004,078.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119003315/0001209191-19-003315-index.htm
2019-02-27JOEL S MARCUSDirectorBuy10,500.0024.05252,525.0043,090.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119014941/0001209191-19-014941-index.htm
2020-05-14Jakob DupontEVP, Head of R&DBuy46,250.0046,250.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120030712/0001209191-20-030712-index.htm
2019-02-06Joe NewellChief Tech. Operations OfficerBuy17,500.0047,146.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119008504/0001209191-19-008504-index.htm
2019-03-01Joe NewellChief Tech. Operations OfficerSell200.0036.757,350.0047,146.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119017038/0001209191-19-017038-index.htm
2019-03-01Joe NewellChief Tech. Operations OfficerSell1,300.0036.0446,852.0047,346.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119017038/0001209191-19-017038-index.htm
2019-02-27JOEL S MARCUSDirectorBuy5,500.0015.0882,940.0048,590.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119014941/0001209191-19-014941-index.htm
2019-03-01Joe NewellChief Tech. Operations OfficerBuy1,500.0020.4030,600.0048,646.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119017038/0001209191-19-017038-index.htm
2020-02-06Joe NewellChief Tech. Operations OfficerSell4,117.0014.2158,502.5753,881.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120008126/0001209191-20-008126-index.htm
2020-04-20Amar MuruganSVP, GC & SecretaryBuy55,000.0055,000.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120025229/0001209191-20-025229-index.htm
2020-03-01Kristin YaremaChief Commercial OfficerBuy55,000.0055,000.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120015360/0001209191-20-015360-index.htm
2019-09-27Joe NewellChief Tech. Operations OfficerSell3,500.0013.5147,285.0057,998.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119051095/0001209191-19-051095-index.htm
2019-02-06Mina KimSenior VP & General CounselBuy17,063.0060,063.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119008514/0001209191-19-008514-index.htm
2019-05-06Joe NewellChief Tech. Operations OfficerSell1,500.0035.0052,500.0061,498.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119027981/0001209191-19-027981-index.htm
2019-03-26Joe NewellChief Tech. Operations OfficerBuy15,000.0062,146.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021443/0001209191-19-021443-index.htm
2019-04-01Joe NewellChief Tech. Operations OfficerSell1,500.0039.9659,940.0062,146.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119023491/0001209191-19-023491-index.htm
2019-01-10Isaac E. CiechanoverChief Executive OfficerSell1,700.0033.9357,681.006,278.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119003315/0001209191-19-003315-index.htm
2019-05-06Joe NewellChief Tech. Operations OfficerBuy1,500.0020.4030,600.0062,998.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119027981/0001209191-19-027981-index.htm
2019-04-01Joe NewellChief Tech. Operations OfficerBuy1,500.0020.4030,600.0063,646.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119023491/0001209191-19-023491-index.htm
2019-02-06Utpal KoppikarChief Financial OfficerBuy17,063.0064,063.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119008568/0001209191-19-008568-index.htm
2019-03-26Mina KimSenior VP & General CounselBuy10,000.0070,063.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021444/0001209191-19-021444-index.htm
2019-02-27JOEL S MARCUSDirectorBuy21,500.0013.20283,800.0070,090.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119014941/0001209191-19-014941-index.htm
2020-02-06Utpal KoppikarChief Financial OfficerSell1,781.0014.2125,308.0172,282.00https://www.sec.gov/Archives/edgar/data/1604464/000120919120008125/0001209191-20-008125-index.htm
2019-03-26Utpal KoppikarChief Financial OfficerBuy10,000.0074,063.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021445/0001209191-19-021445-index.htm
2019-02-28JOEL S MARCUSDirectorSell62,590.0036.072,257,621.307,500.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119014941/0001209191-19-014941-index.htm
2019-02-06Dietmar BergerGlobal Head of R&DBuy25,000.0075,000.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119008518/0001209191-19-008518-index.htm
2019-01-09Isaac E. CiechanoverChief Executive OfficerSell2,000.0035.1670,320.007,978.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119003315/0001209191-19-003315-index.htm
2019-03-15JOEL S MARCUSDirectorSell20,000.0038.25765,000.00888,355.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119020276/0001209191-19-020276-index.htm
2019-03-26Dietmar BergerGlobal Head of R&DBuy15,000.0090,000.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119021442/0001209191-19-021442-index.htm
2019-06-27Carol Giltner GallagherDirectorBuy4,000.0092,818.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119039767/0001209191-19-039767-index.htm
2019-01-09Isaac E. CiechanoverChief Executive OfficerSell1,900.0034.5165,569.009,978.00https://www.sec.gov/Archives/edgar/data/1604464/000120919119003315/0001209191-19-003315-index.htm